The trial met both endpoints in the readout, removing the inconclusive outcome management itself had flagged, and short ...

Moderna's melanoma vaccine is generating buzz after a Phase 3 breakthrough. But can it actually cure skin cancer? What ...

People given the experimental vaccine with standard treatment lived longer without their cancer returning, the companies ...

A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the ...

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big ...

By Michael Erman and Julie Steenhuysen Aug 19 (Reuters) - Moderna and Merck said on Wednesday that a personalized mRNA cancer ...

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of ...

Dr. Jonathan Reiner says the study puts us on the precipice of a breakthrough in cancer therapy.

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.

Moderna Inc (NASDAQ:MRNA, XETRA:0QF)'s melanoma trial success is prompting Wall Street to assign new platform value to the company's oncology pipeline, Jefferies said, as investors look beyond its ...

Moderna and Merck announced that a personalized mRNA melanoma vaccine met key goals in a Phase 3 trial. It could become ...